Managing eczema in children—a treatment update

,; ,; ,

Applied Evidence

Managing eczema in children—a treatment update

J Fam Pract. 2011 November;60(11):660-668

PDF Download

References

1. Boguniewicz M, Leung D. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010;125:4-13.

2. Lucinda BM. Treatment options for atopic dermatitis. Am Fam Physician. 2007;75:523-530.

3. Levy ML. Atopic dermatitis: understanding the disease and its management. Curr Med Res Opin. 2007;23:3091-3103.

4. Brown S, Reynolds NJ. Atopic and non-atopic eczema. BMJ. 2006;332:584-588.

5. Carbone A, Siu A, Patel R, et al. Pediatric atopic dermatitis: a review of the medical management. Ann Pharmacother. 2010;44:1448-1458.

6. Akadis CA, Akadis M, Beiber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report. Allergy. 2006;61:969-987.

7. Schafer T. The impact of allergy on atopic eczema from data from epidemiological studies. Curr Opin Allergy Clin Immunol. 2008;8:418-422.

8. Charman C, Williams H. The use of corticosteroids and corticosteroid phobia in atopic dermatitis. Clin Dermatol. 2003;21:193-200.

9. National Collaborating Centre for Women’s and Children’s Health. Atopic eczema in children. Management of atopic eczema in children from birth up to age of 12 years. Clinical guideline no. 57. London, UK: National Institute for Health and Clinical Excellence (NICE); 2007.

10. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments of atopic eczema. Health Technol Assess. 2000;4:1-191.

11. Simpson E, Hanifin J. Atopic dermatitis. J Am Acad Dermatol. 2005;53:115-128.

12. Grimalt R, Mengeaud V, Cambazard F, et al. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology. 2007;214:61-67.

13. Callen J, Chamlin S, Eichenfield LF, et al. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol. 2007;156:203-221.

14. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines for the care of atopic dermatitis developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association. “Administrative regulations for evidence-based clinical practice guidelines”. J Am Acad Dermatol. 2004;50:391-404.

15. Simpson E. Atopic dermatitis: a review of topical treatment options. Curr Med Res Opin. 2010;26:633-640.

16. Munzenberger PJ, Monejo JM. Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Pharmacotherapy. 2007;27:1020-1028.

17. Kang S, Lucky AW, Pariser D, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol. 2001;44(suppl):S58-S64.

18. Devillers ACA, Oranje AP. Efficacy and safety of ‘wet wrap’ dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature. Br J Dermatol. 2006;154:579-585.

19. Boyl RJ, Bath-Hextall FJ, Leonardi-Bee J, et al. Probiotics for treating eczema. Cochrane Database Syst Rev. 2008;(4):CD006135.-

20. Ellis C, Luger T. International Consensus Conference of Atopic Dermatitis (ICCAD II*): clinical update and current treatment strategies. Br J Dermatol. 2003;148(suppl 63):S3-S10.

21. Han KL, Leung TF, Ching G, et al. Patterns of food and aeroallergen sensitization in childhood eczema. Acta Pediatrica. 2008;97:1734-1737.

22. Greenhawt M. The role of food allergy in atopic dermatitis. Allergy Asthma Proc. 2010;31:392-397.

23. Langan SM, Williams HC. What causes worsening of eczema? A systemic review. Br J Dermatol. 2006;155:505-514.

24. Eller E, Kjaer HF, et al. Food allergy and food sensitization in early childhood: results from the DARC cohort. Allergy. 2009;63:1023-1029.

25. Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361:151-160.

26. Protopic [prescribing information]. Deerfield, IL: Astellas Pharma US, Inc; 2006.

27. Elidel [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2006.

28. US Food and Drug Administration. Topical calcineurin inhibitors. Pediatric safety update: regulatory background. FDA Pediatric Advisory Committee Meeting; March 22, 2010; Bethesda, Md.

29. Kalavala M, Dohil MA. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence. Am J Clin Dermatol. 2011;12:15-24.

30. Ricci G, Dondi A, Patrizi A, et al. Systemic therapy of atopic dermatitis in children. Drugs. 2009;69:297-306.